Form 4: STERIS Executive's Routine Share Vesting & Tax Withholding

A STERIS plc Senior VP reported the vesting of restricted shares and subsequent tax withholding, a routine insider transaction.

Summary

• John Adam Zangerle, Senior VP, General Counsel, and Secretary of STERIS plc, reported a change in beneficial ownership.
• On October 1, 2025, 202 restricted ordinary shares, which were initially awarded on October 1, 2021, vested.
• 91 ordinary shares were withheld from these vested shares to cover tax obligations, with the value determined by the NYSE closing market price on October 1, 2025.
• Following this transaction, Mr. Zangerle beneficially owns 33,669 ordinary shares.
• Of the beneficially owned shares, 8,511 remain restricted, with various vesting dates scheduled through June 5, 2028.

Sentiment

Score: 5

Explanation: The filing reports a routine executive compensation event (restricted stock vesting and tax withholding), which is neutral in terms of company performance or outlook.

Positives

• Vesting of 202 restricted shares indicates a successful completion of a performance or tenure period for the executive.
• The executive continues to hold a significant number of shares (33,669), aligning his interests with shareholders.

Negatives

• A reduction of 91 shares from the executive's direct ownership due to tax withholding.

Future Outlook

The filing details future vesting schedules for 8,511 restricted ordinary shares held by Mr. Zangerle, with dates extending through June 5, 2028.

Industry Context

This is a routine insider transaction related to executive compensation, common across all industries for publicly traded companies, and does not reflect specific industry trends for STERIS plc.

Stakeholder Impact

• Shareholders: Minor, routine adjustment to executive share ownership, reflecting standard compensation practices.
• Employees: No direct impact beyond the executive involved.

Next Steps

• Future vesting of 1,157 restricted ordinary shares on June 1, 2026.
• Future vesting of 846 restricted ordinary shares on June 2, 2026.
• Future vesting of 1,252 restricted ordinary shares on June 3, 2026.
• Future vesting of 1,376 restricted ordinary shares on June 4, 2026.
• Future vesting of 1,252 restricted ordinary shares on June 3, 2027.
• Future vesting of 1,376 restricted ordinary shares on June 4, 2027.
• Future vesting of 1,252 restricted ordinary shares on June 5, 2028.

Key Dates

Keywords

STERIS plc, STE, Form 4, Insider Transaction, Restricted Stock, Share Vesting, Tax Withholding, Executive Compensation, John Adam Zangerle